ArticleJPRAS open2025
Orthoplastic surgery research: Three decades of growth and future directions.
Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- [The acute orthoplastic patient : Definition and initial management recommendations: consensus statement of the Orthoplastic Surgery Working Group of the German Society for Trauma Surgery (DGU) and the German Society of Plastic, Reconstructive and Aesthetic Surgeons (DGPRÄC)].Unfallchirurgie (Heidelberg, Germany) · 2026Review
- Orthoplastic surgery for interdisciplinary extremity reconstruction.Innovative surgical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Six clinical databases were analysed from inception through 2023 to assess the trajectory of orthoplastic surgery research and provide a scoping review of concentrations and gaps in the literature. The literature grew exponentially since 2010, with 66 % of identified studies published between 2020 and 2024. The United Kingdom emerged as the primary contributor, accounting for 47 % of publications following national guideline implementation that demonstrated improved patient outcomes. While meta-analyses support the clinical benefits of orthoplastic management for complex fractures, showing reduced surgical interventions and infection rates, the evidence base relies predominantly on retrospective studies, with no randomized controlled trials identified. Key opportunities to strengthen the field include conducting prospective studies, expanding research beyond lower extremity trauma to areas such as upper extremity reconstruction, oncologic applications, and paediatric care, addressing healthcare access disparities, evaluating cost-effectiveness across different healthcare systems, and developing standardized guidelines beyond the UK.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.